Who Should Avoid MOTS-c Pregnant or breastfeeding individuals People with an active cancer diagnosis, since MOTS-c may affect prostate and breast cancer pathways Those taking AMPK-activating medications like metformin, thiazolidinediones, or aspirin Anyone on insulin or with uncontrolled diabetes without medical supervision Minors and adolescents Athletes in tested sports, since MOTS-c is on the WADA Prohibited List under Section S4 Anyone without access to lab-verified research peptides MOTS-c vs Other Metabolic Peptides (High-Level Comparison) MOTS-c vs Semaglutide MOTS-c works through the mitochondrial pathway with gradual, muscle-preserving results
is an inventor of patents that have been or may be licensed to companies developing microneedle-based products, is a paid advisor to companies developing microneedle-based products and is a founder/shareholder of companies developing microneedle-based products, including Micron Biomedical
Compounds of trace elements: E1 (Fe) 40.0 mg, E6 (Zn) 11.2 mg, E5 (Mn) 8.4 mg, E4 (Cu) 2.0 mg, E2 (I) 0.25 mg, E8 (Se) 0.24 mg, E7 (Mo) 0.06 mg
enzymatic antioxidants compare gives hydrogen water unique advantages in bioavailability and cellular penetration, allowing it to reach virtually every cell in the body without the size limitations and degradation issues that enzymatic antioxidants face when taken as supplements
Plasma glutathione levels, oxidative stress markers (8-OHdG, F2-isoprostanes), inflammatory markers (CRP, IL-6), and symptom history inform supplementation relevance
